One connected platform
EDC, RTSM, eCOA, IRC, CTMS, eTMF, RM, eLearning, analytics, and supporting services in one operating model.
Global clinical research · Connected
One connected platform. Clinical research without borders.
EClinCloud connects study operations, clinical data, endpoint assessment, analytics, and AI-enabled workflows for research teams worldwide — backed by regional expertise and cross-border delivery.
Global platform · Regional delivery21 CFR Part 11 · EU Annex 11Multilingual study operations
One platform and one delivery model across the study lifecycle
China depth · Global reach
Built in China. Ready for studies worldwide.
Local operating knowledge, region-ready workflows, and responsive support connect with the standards, visibility, and full-lifecycle delivery global research teams expect.
China delivery depth
Local teams, Chinese-language workflows, site onboarding, and responsive support grounded in day-to-day study execution.
Global standards built in
Quality and technology practices designed around ICH GCP, 21 CFR Part 11, EU Annex 11, auditability, and responsible AI governance.
Visibility across borders
Give global sponsors and CROs consistent oversight while regional teams work in tools and processes designed for local realities.
Our missionBetter treatment through innovative technology.
Patient-centered technology, clinical data and expert services — connected to help research teams create more reliable evidence.
Why one platform
Many systems don't make a connected study.
Connected data
Fewer silos, less duplicate entry, no manual re-keying between sponsors, sites and participants.
Better execution
Unified workflows, real-time visibility and cross-team collaboration raise delivery quality and speed.
Confident decisions
Traceable evidence, analytics and AI surface issues earlier — so judgments hold up.
The Platform
One unified clinical evidence platform
Every role, every data point and every decision on the same connected foundation.
RegulatorsSponsorsCROsSitesParticipants
Clinical data & endpoints
Study operations
Intelligence
Integrations & APISecurityAuditabilityGlobal delivery
Embedded AI
AI in the workflow, not on the side
01
Protocol → study build
The embedded AI agent parses the protocol and drafts EDC forms and edit checks — cutting build time by 60%+, with your team reviewing before anything goes live.
02
OCR-assisted entry
Medical OCR and multimodal recognition cover 1,000+ form types at 95%+ accuracy, turning source documents into structured, checkable data.
03
Document & risk intelligence
TMF documents are classified and filed automatically; AI models scan study risk signals and suggest actions.
04
Multilingual support agent
A 24/7 assistant answers questions, sends reminders and guides data entry across global sites in multiple languages.
Find your starting point
Products grouped by the job they do — each one connected to the rest.
EDC · Electronic Data Capture
AI-driven study build and OCR-assisted capture on one ALCOA+ compliant EDC platform.
→ Protocol-driven AI study build — 60% less effort
→ AI-powered OCR capture at 95% accuracy
RTSM · Randomization and Trial Supply Management
Randomization and supply for multicenter trials — flexible designs, intelligent supply alerts.
→ AI one-step configuration — 10–20% less build effort
→ Drug lifecycle management with smart alerts
eCOA · Electronic Clinical Outcome Assessment
Five COA dimensions on one global, multilingual platform with AI-assured capture quality.
→ Full coverage: ePRO, eClinRO, eObsRO, ePerfO, eDiary
→ AI-guided capture lifted pass rates from 40% to ~95%
IRC · Independent Review Committee
A GxP-aligned platform unifying image upload and independent review, with expert readers.
→ One-stop independent review — controlled and traceable
→ Senior readers across oncology and beyond
Evidence
Proven in real studies
Supporting sponsor-run programs, CRO-led studies and investigator-initiated research across oncology, CNS, immunology, endocrinology, respiratory, cardiovascular and more.
Experience by study stage
Who we work with
Global delivery, regional depth
Multi-language workflows, regional deployment options and cross-border training — deployed across study sites in the US, Canada, UK, Spain, Poland, Australia, New Zealand and more.
China
HQ Ningbo · Beijing · Shanghai · Chengdu · Shenzhen
United States
New York office · NA delivery
Japan
Regional study workflows
Singapore
APAC coordination
Built for trust
Security, privacy, validation and responsible AI governance are part of the platform — not an afterthought.
21 CFR Part 11 · EU Annex 11 · ICH E6(R3) · GAMP 5 · CDISC · China GCP
ISO 27001 / 27701 security & privacy · GDPR · HIPAA · CSA STAR
ISO/IEC 42001:2023 AI Management System certification
End-to-end audit trail · quality & system validation
Resources
Insights & news
Clinical Trial Protocol Complexity 2026: Endpoints, Multicenter Countries and Study-Build Workload on ClinicalTrials.govPublic protocol files store outcome, group, country and facility multipliers, not EDC hours. Median studies are small; Phase 3 industry interventional trials sit on a different build surface.
FDA PFDD Guidance 3 and ClinicalTrials.gov 2026: PRO vs ClinRO Tokens, Patient-Reported Outcome Registration, and eCOA ImplementationFDA PFDD Guidance 3 is a fit-for-purpose selection file. ClinicalTrials.gov outcome text almost never stores COA type; PRO language is common and still not validation.
FDA Warning Letters, BIMO Computerized Systems and 21 CFR 312.62 Records in 2026: What Clinical Trial Data Integrity, Part 11 and eTMF Inspections Actually CiteFDA warning letters and BIMO observations cite investigator records and protocol compliance far more than EDC or eTMF products. Part 11 is not the dominant public inspection object.